Treatment Approach for Cannabis Toxicity
The definitive treatment for cannabis toxicity is complete cannabis cessation, supported by symptom-directed supportive care tailored to the specific presentation. 1
Acute Cannabis Toxicity Management
First-Line Interventions
- IV fluid rehydration for dehydration from vomiting
- Dopamine receptor antagonists for nausea/vomiting:
- Haloperidol 0.5-2 mg IV or PO every 4-6 hours 1
- Topical capsaicin cream (0.1%) applied to abdomen for symptomatic relief 1
- Hot showers/baths can provide temporary symptom relief, particularly in cannabinoid hyperemesis syndrome 1
Second-Line Options
- Benzodiazepines for anxiety and agitation:
- Lorazepam 0.5-2 mg PO/SL/IV every 6 hours 1
- Olanzapine 5-10 mg PO daily for persistent nausea/vomiting 1
- Corticosteroids for severe symptoms 1
Specific Symptom Management
- For seizures: Standard anticonvulsant therapy
- For tachycardia: Beta-blockers (propranolol) have shown effectiveness 2
- For psychosis/anxiety: Antipsychotics and benzodiazepines 2
- For severe intoxication: Rimonabant (CB1 receptor antagonist) has shown promise in research but is not widely available 2
Special Populations
Pediatric Patients
- More aggressive supportive care as children are more susceptible to cannabis toxicity, particularly seizures and coma 3
- Lower threshold for admission for observation
- Close monitoring for respiratory depression
Elderly Patients
- Monitor closely for sedation, obtundation, and myocardial ischemia 4
- Adjust medication doses due to altered metabolism and increased sensitivity
Cannabinoid Hyperemesis Syndrome (CHS)
CHS is characterized by cyclic vomiting in chronic cannabis users and requires specific management:
Identify CHS by stereotypical episodic vomiting in patients with:
- Cannabis use for >1 year
- Cannabis use frequency >4 times per week
- Relief from hot showers/baths
- Resolution after cannabis cessation 1
Treatment protocol:
Long-Term Management
For patients with cannabis use disorder:
- Cognitive behavioral therapy and motivational enhancement therapy 5
- Supportive environment with minimal stimulation 1
- Monitor for complications such as depression or psychosis during withdrawal 1
- Manage specific withdrawal symptoms:
- Acetaminophen or NSAIDs for headaches and pain
- Benzodiazepines for severe anxiety and agitation 1
Clinical Pearls and Pitfalls
- Always rule out life-threatening conditions in the differential diagnosis (acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, myocardial infarction) 1
- Avoid cannabis-drug interactions, particularly with warfarin, buprenorphine, and tacrolimus 1
- Recognize that THC concentration correlates with symptom intensity and duration 3
- Be aware that children are more vulnerable to cannabis toxicity and may require more intensive supportive care 3, 6
- Consider cannabidiol (CBD) as a potential therapeutic agent to attenuate THC-associated anxiety and tachycardia, though more research is needed 7
By following this structured approach to cannabis toxicity management, clinicians can effectively address both acute symptoms and support long-term recovery while minimizing complications.